Where does Maximum Fidelity Surgical Simulations, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Maximum Fidelity Surgical Simulations, LLC ranks #41,605 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Maximum Fidelity Surgical Simulations, LLC hold?

Maximum Fidelity Surgical Simulations, LLC holds 6 US utility patents granted between 2019 and 2024, spanning 2 technology areas.

What is Maximum Fidelity Surgical Simulations, LLC's Innovation Score?

Maximum Fidelity Surgical Simulations, LLC has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Maximum Fidelity Surgical Simulations, LLC's patent grant rate increasing or decreasing?

Maximum Fidelity Surgical Simulations, LLC's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Maximum Fidelity Surgical Simulations, LLC's patents?

Maximum Fidelity Surgical Simulations, LLC's patents average 19.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Maximum Fidelity Surgical Simulations, LLC

Q: What technology areas does Maximum Fidelity Surgical Simulations, LLC focus on?

Maximum Fidelity Surgical Simulations, LLC's top technology area is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators) with 6 patents, ranking #234 of 1,216 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Q: How is the Maximum Fidelity Surgical Simulations, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Maximum ranks #41,605 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.

#41,605
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 19.2
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41605 · US Corporation #41,605 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,605/49,997
PHOTO-FINISH Matinas Biopharma…
CPC-NARROW A01N · 2 areas
INNOV-THIN 36.6/100
CLAIMS-RICH 19.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Matinas Biopharma Nanotechnologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Maximum’s 36.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (18%) Velocity 13.3 pts (36%) Breadth 5.0 pts (14%) Claim depth 11.5 pts (32%)

Qualcomm Incorporated · highest

85
Maximum Fidelity… · this assignee

37
3D Lighting… · lowest

7

What this shows Maximum's Innovation Score is 36.6/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Maximum?

Each dot is one of Maximum’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maximum’s own 19.2 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Maximum vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Maximum's grants concentrate

Maximum Fidelity Surgical Simulations, LLC is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2019. By volume, Maximum sits between Matinas Biopharma Nanotechnologies, Inc. and MC2 Therapeutics, Ltd..

Maximum's three-year grant acceleration

Maximum Fidelity Surgical Simulations, LLC shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Matinas Biopharma…

6
Matrix Design Gro…

6
Mattrix

6
Mavrik Dental Sys…

6
Maximus

6
Maxlead Innovatio…

6
Maxphotonics

6
MC2 Therapeutics

6
Maximum Fidelity… ◀

6

What this shows Maximum holds 6 patents at rank #41,534, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Maximum

By rank, the assignees closest to #41,534 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Maximum's primary technology class.

Maximum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Maximum Fidelity Surgical Simulations, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	16.7%
2020	1	16.7%
2022	1	16.7%
2023	1	16.7%
2024	2	33.3%

Which technologies does Maximum Fidelity Surgical Simulations, LLC patent most?

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 6

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Maximum Fidelity Surgical Simulations, LLC's patent record in context - here's where to go next.

Maximum Fidelity Surgical Simulations, LLC's lead technology class is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators), 100% of its portfolio - see every assignee active in that class. Explore A01N
Ranked #41,605 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Maximum Fidelity Surgical Simulations, LLC against Matinas Biopharma Nanotechnologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.